Arkolith/Insider Trading/BEAM/Form 4

Ciaramella Giuseppe

PresidentBeam Therapeutics Inc. (BEAM) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Option exercise(M)35K$17.00$595K225K
Feb 24, 2026Sell(S)35K$32.00$1.1M190K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2026Option exercise(M)35K—$0397K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-076544) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML